FMR LLC - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$190,447,555
-36.2%
9,493,896
-10.2%
0.02%
-36.0%
Q2 2023$298,365,097
-2.7%
10,576,572
-40.7%
0.02%
+78.6%
Q1 2023$306,598,634
+92.5%
17,825,502
+125.4%
0.01%
-12.5%
Q4 2022$159,290,805
-2.8%
7,909,176
+4.5%
0.02%
-5.9%
Q3 2022$163,958,000
-25.0%
7,569,606
-2.7%
0.02%
-22.7%
Q2 2022$218,510,000
-29.8%
7,776,168
+15.3%
0.02%
-12.0%
Q1 2022$311,109,000
-45.5%
6,742,694
-0.8%
0.02%
-40.5%
Q4 2021$571,257,000
+26.8%
6,795,831
+0.6%
0.04%
+16.7%
Q3 2021$450,348,000
+27.1%
6,757,935
+1.4%
0.04%
+28.6%
Q2 2021$354,431,000
+32.7%
6,662,225
+8.2%
0.03%
+21.7%
Q1 2021$267,111,000
-15.6%
6,156,042
+1.0%
0.02%
-17.9%
Q4 2020$316,422,000
+238.7%
6,092,078
+113.2%
0.03%
+211.1%
Q3 2020$93,425,000
-15.8%
2,857,920
+23.7%
0.01%
-25.0%
Q2 2020$110,972,0002,310,9460.01%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 1,824,583$39,520,00014.33%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,301,771$49,857,0004.79%
Matrix Capital Management Company, LP 9,199,973$199,271,0003.81%
Integral Health Asset Management, LLC 550,000$11,913,0002.31%
Avidity Partners Management LP 4,223,100$91,472,0001.86%
Affinity Asset Advisors, LLC 170,000$3,682,0001.03%
Eventide Asset Management 1,861,000$40,309,0000.79%
Sofinnova Investments, Inc. 583,357$12,636,0000.74%
Nicholas Investment Partners, LP 158,704$3,438,0000.32%
SECTORAL ASSET MANAGEMENT INC 60,000$1,300,0000.26%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders